Imperial College London

Professor Nilay Shah OBE FREng

Faculty of EngineeringDepartment of Chemical Engineering

Professor of Process Systems Engineering
 
 
 
//

Contact

 

+44 (0)20 7594 6621n.shah

 
 
//

Assistant

 

Miss Jessica Baldock +44 (0)20 7594 5699

 
//

Location

 

ACEX 522ACE ExtensionSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Papathanasiou:2020:10.1038/s41417-019-0157-z,
author = {Papathanasiou, MM and Stamatis, C and Lakelin, M and Farid, S and Titchener-Hooker, N and Shah, N},
doi = {10.1038/s41417-019-0157-z},
journal = {Cancer Gene Therapy},
pages = {799--809},
title = {Autologous CAR T-cell therapies supply chain: challenges and opportunities?},
url = {http://dx.doi.org/10.1038/s41417-019-0157-z},
volume = {27},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Chimeric antigen receptor (CAR) T cells are considered a potentially disruptive cancer therapy, showing highly promisingresults. Their recent success and regulatory approval (both in the USA and Europe) are likely to generate a rapidly increasingdemand and a need for the design of robust and scalable manufacturing and distribution models that will ensure timely andcost-effective delivery of the therapy to the patient. However, there are challenging tasks as these therapies are accompaniedby a series of constraints and particularities that need to be taken into consideration in the decision-making process. Here, wepresent an overview of the current state of the art in the CAR T cell market and present novel concepts that can debottleneckkey elements of the current supply chain model and, we believe, help this technology achieve its long-term potential.
AU - Papathanasiou,MM
AU - Stamatis,C
AU - Lakelin,M
AU - Farid,S
AU - Titchener-Hooker,N
AU - Shah,N
DO - 10.1038/s41417-019-0157-z
EP - 809
PY - 2020///
SN - 0929-1903
SP - 799
TI - Autologous CAR T-cell therapies supply chain: challenges and opportunities?
T2 - Cancer Gene Therapy
UR - http://dx.doi.org/10.1038/s41417-019-0157-z
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000508143300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - http://hdl.handle.net/10044/1/76421
VL - 27
ER -